A

Aether Industries Ltd

Q4 FY25Chemicals & Petrochemicals

Aether Industries Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price1,627
Market cap₹21.1K Cr
P/E87.9
Updated23 Aug 2026
Read5 min read

The short version

Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25. Aether Industries expects to maintain or grow EBITDA margins around 29%-30% in the near term, with gradual improvement beyond that.

From Aether Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25.
  • Pricing has remained stable over the past six months, supporting strong demand.
  • The company aims to shift revenue mix to 70% from CRAMS and CEM business models and 30% from large-scale manufacturing, indicating growth in higher-margin contract manufacturing segments.
  • Site-4 has been commercialized with full production and is expected to ramp up further in FY26 and FY27.
  • Site-3++ is dedicated to a key client under a CEM model, with production anticipated to start by end of Q3 FY26.
  • Site-5 expansion is advancing, with first two production blocks expected to commission by December 2025.
  • Management is optimistic about continued growth driven by strategic partnerships, increasing CRAMS and CEM contracts, and the favorable global chemical industry environment.

Profitability & Margins

See what Aether Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Aether Industries is expanding its R&D center at Site-1, doubling the R&D capacity to support the CRAMS business model.
  • Site-3++ is being developed and dedicated to a key client under the Contract/Exclusive Manufacturing (CEM) business model, with production expected to start by end of Q3 FY 2026.
  • Site-4 has been successfully commercialized and is operating at full capacity.
  • Site-5 expansion is progressing, with two production blocks on track for commissioning by December 2025; additional 15 acres acquired at Site-5 totaling 46 acres, earmarked for large customers like Baker Hughes.
  • The company plans to invest significantly and strategically in R&D, aiming to increase R&D spend possibly to 10%-12% of revenues.
  • Solar power initiatives are expanding, saving Rs. 188 million in FY 25 and reducing electricity costs at production sites.
  • Internal goal of sustaining ~30% EBITDA margins while scaling operations through these expansions.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Aether Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The contract with Baker Hughes is being finalized, and once finalized, orders are expected to follow immediately (Page 12).
  • No specific current order book size or value is mentioned publicly; discussions indicate a pipeline of strategic partnerships and contracts being developed, especially in CRAMS and CEM businesses (Page 11).
  • Site-4 has started commercial supplies from April with existing confirmed orders (Page 13).
  • Site-3++ is dedicated to a CEM business model with production anticipated to begin by end of Q3 FY 2026, indicating upcoming order fulfillment capacity (Page 4).
  • Management refrained from disclosing specific contract details or product names due to confidentiality but indicated robust order inflow aligned with growth in Contract Manufacturing and CRAMS segments (Page 10).

Aether Industries Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹305 Cr, net profit ₹54 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Clean Science (Q4 FY25)

    2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Yasho Industries (Q4 FY25)

    Exports continue to be a key revenue driver, contributing around 67% of total revenue. Key concall takeaways from Yasho Industries's Q4 FY25 earnings call…

  • Vinati Organics (Q4 FY25)

    Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…

  • PCBL Chemical (Q4 FY25)

    Export sales volume for Carbon Black grew strongly by 16.8% in Q4 FY'25, reflecting strong international demand. Key concall takeaways from PCBL Chemical's Q4…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Aether Industries Ltd Q4 FY25 results?

Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25. Aether Industries expects to maintain or grow EBITDA margins around 29%-30% in the near term, with gradual improvement beyond that.

What is Aether Industries Ltd share price analysis?

Aether Industries Ltd currently shows a neutral. The stock trades at a P/E of 87.9 with a market cap of ₹21,093 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aether Industries Ltd planning capital expenditure?

Aether Industries is expanding its R&D center at Site-1, doubling the R&D capacity to support the CRAMS business model. - Site-3++ is being developed and dedicated to a key client under the Contract/Exclusive Manufacturing (CEM) business model, with production expected to start by end of Q3 FY 2026. - Site-4 has been successfully commercialized and is operating at full capacity. - Site-5 expansion is progressing, with two production blocks on track for commissioning by December 2025; additional 15 acres acquired at Site-5 totaling 46 acres, earmarked for large customers like Baker Hughes. - The company plans to invest significantly and strategically in R&D, aiming to increase R&D spend possibly to 10%-12% of revenues. - Solar power initiatives are expanding, saving Rs.

Keep Aether Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.